Intolerance to 5-aminosalicylate is a risk of poor prognosis in ulcerative colitis patients

被引：0
|
作者：
Fujii, T. [1 ]
Hibiya, S. [1 ]
Maeyashiki, C. [2 ]
Saito, E. [1 ]
Takenaka, K. [1 ]
Motobayashi, M. [1 ]
Shimizu, H. [1 ]
Nagahori, M. [1 ]
Ohtsuka, K. [1 ]
Kurosaki, M. [2 ]
Yauchi, T. [3 ]
Watanabe, M. [1 ]
机构：
[1] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan
[2] Musashino Red Cross Hosp, Gastroenterol, Tokyo, Japan
[3] Soka Municipal Hosp, Gastroenterol, Soka, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P461
引用
收藏
页码：S409 / S410
页数：2
相关论文
共 50 条
  • [1] 5-Aminosalicylate intolerance causing exacerbation in pediatric ulcerative colitis
    Shimizu, Hirotaka
    Arai, Katsuhiro
    Tang, Julian
    Hosoi, Kenji
    Funayama, Rie
    PEDIATRICS INTERNATIONAL, 2017, 59 (05) : 583 - 587
  • [2] Ketotifen treatment of active colitis in patients with 5-aminosalicylate intolerance
    Marshall, JK
    Irvine, EJ
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1998, 12 (04): : 273 - 275
  • [3] 5-Aminosalicylate is Not Protective From Neoplasia in Ulcerative Colitis
    Bessissow, Talat
    Bisschops, Raf
    Ferrante, M.
    Baert, F.
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06): : 1015 - 1015
  • [4] 5-Aminosalicylate intolerance is a risk factor for hospitalization in patients with UC
    Yusuke, Yoshimatsu
    Shinta, Mizuno
    Makoto, Naganuma
    Tomohiro, Fukuda
    Ena, Nomura
    Kosuke, Yoshida
    Satoko, Umeda
    Keiko, Ono
    Shinya, Sugimoto
    Kosaku, Nanki
    Yohei, Mikami
    Kayoko, Kimura
    Makoto, Mutaguchi
    Tomohisa, Sujino
    Kaoru, Takabayashi
    Haruhiko, Ogata
    Yasushi, Iwao
    Takanori, Kanai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S6 - S7
  • [5] A clinical trial of rosiglitazone and 5-aminosalicylate combination for ulcerative colitis
    梁红亮
    China Medical Abstracts(Internal Medicine), 2006, (04) : 217 - 217
  • [6] A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis
    Hong-Liang Liang
    World Journal of Gastroenterology, 2008, (01) : 114 - 119
  • [7] A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis
    Liang, Hong-Liang
    Ouyang, Qin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (01) : 114 - 119
  • [8] Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis
    Wiggins, Jon Brendan
    Rajapakse, Ramona
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (10) : 1279 - 1284
  • [9] REFRACTORY DISTAL ULCERATIVE-COLITIS RESPONSIVE TO 5-AMINOSALICYLATE ENEMAS
    BARBER, GB
    LEE, DE
    ANTONIOLI, DA
    PEPPERCORN, MA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1985, 80 (08): : 612 - 614
  • [10] Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis - methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa
    Lichtenstein, G. R.
    Kamm, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (06) : 663 - 673
12345